These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 27170311)

  • 21. [Clinical efficacy of various antiviral-based strategies to treat chronic hepatitis patients with positivity for hepatitis B e antigen and rtN236T mutation].
    Yue W; Yuan H; Mao XR; Deng YD; Chen L
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):184-8. PubMed ID: 23967738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatitis B virus genotypes and alanine aminotransferase levels in HBeAg negative patients with chronic hepatitis B and liver cirrhosis].
    Li JQ; Zhuang H; Du H; Wang XH; Duan XZ
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):491-3. PubMed ID: 16042881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between serum platelet-derived growth factor BB and degree of liver damage, fibrosis and hepatitis B e antigen (HBeAg) status in CHB patients.
    Diang XC; Ma LN; Li YF; Liu XY; Zhang X; Liu JY; Sheng YJ; Zhang DZ; Hu HD; Ren H
    Hepatogastroenterology; 2012; 59(120):2357-60. PubMed ID: 22688015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.
    Lesmana CR; Gani RA; Hasan I; Simadibrata M; Sulaiman AS; Pakasi LS; Budihusodo U; Krisnuhoni E; Lesmana LA
    J Dig Dis; 2011 Dec; 12(6):476-80. PubMed ID: 22118698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B.
    Hu J; Zhang X; Gu J; Yang M; Zhang X; Zhao H; Li L
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):817-823. PubMed ID: 30543572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
    Kim KH; Na IH; Cha JM; Cho YK; Park SY; Kim HP; Song CS; Heo J; Cho M
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
    Papatheodoridis GV; Manesis EK; Manolakopoulos S; Elefsiniotis IS; Goulis J; Giannousis J; Bilalis A; Kafiri G; Tzourmakliotis D; Archimandritis AJ
    Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal.
    Gao S; Fan YC; Zhao J; Sun FK; Han J; Zhao ZH; Wang K
    Liver Int; 2014 Aug; 34(7):e229-37. PubMed ID: 24112455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: A multicentre-based study in China.
    Xing YF; Zhou DQ; He JS; Wei CS; Zhong WC; Han ZY; Peng DT; Shao MM; Sham TT; Mok DK; Chan CO; Tong GD
    PLoS One; 2018; 13(9):e0203220. PubMed ID: 30180183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume.
    Ke WM; Xie SB; Li XJ; Zhang SQ; Lai J; Ye YN; Gao ZL; Chen PJ
    J Viral Hepat; 2011 Sep; 18(9):637-45. PubMed ID: 21794025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B.
    Croagh CM; Bell SJ; Slavin J; Kong YX; Chen RY; Locarnini S; Desmond PV
    Liver Int; 2010 Sep; 30(8):1115-22. PubMed ID: 20492511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GP73 level in patients with chronic hepatitis B: Relationship with liver biopsy, levels of ALT, AST and HBV DNA.
    Atilla A; Taşkın MH; Kazak Z; Aydın S; Kılıç SS
    Indian J Pathol Microbiol; 2022; 65(1):55-58. PubMed ID: 35074966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.
    Lapalus M; Laouenan C; Cardoso AC; Estrabaud E; Carvalho-Filho RJ; Zhang Q; Lada O; Appourchaux K; Mouri F; Boyer N; Bedossa P; Asselah T; Martinot-Peignoux M; Marcellin P
    Liver Int; 2015 Sep; 35(9):2082-9. PubMed ID: 25612083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
    Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
    Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis.
    Zheng RD; Xu CR; Jiang L; Dou AX; Zhou K; Lu LG
    Int J Med Sci; 2010 Aug; 7(5):272-7. PubMed ID: 20714438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of cytokines with hepatitis B virus and its antigen.
    Li MH; Chen QQ; Zhang L; Lu HH; Sun FF; Zeng Z; Lu Y; Yi W; Xie Y
    J Med Virol; 2020 Dec; 92(12):3426-3435. PubMed ID: 32662892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of quantitative hepatitis B core antibody (qHBcAb) and aspartate aminotransferase (AST) can accurately diagnose immune tolerance of chronic hepatitis B virus infection based on liver biopsy.
    Chi Z; Zhao W; Li JW; Liu H; Shao C; Zhao H; Gui-Qiang W
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101563. PubMed ID: 33272888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of intrahepatic total hepatitis B virus DNA in chronic hepatitis B patients and its relationship with liver histology.
    Bayram A; Erkilic S; Ozkur A; Bayram M; Sari I
    J Clin Pathol; 2008 Mar; 61(3):338-42. PubMed ID: 17693576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.